Confirm
Technical Service

Technology Platform For Large-Scale Cell Culture Processes

Large-scale Process Production Line Design Services

Personalized Custom Cell Information Sheet

Technology Platform For Large-Scale Cell Culture Processes

ToCell remains committed to driving technological innovation, continually enhancing its technical capabilities, and offering superior products and services to customers. Our goal is to help China’s biopharmaceutical industry explore the depth and breadth of biotechnology, contributing to the development of the country’s biopharmaceutical sector. We focus on the research and production of personalized cell culture media, the process design and manufacture of bioreactors, large-scale culture technology research for animal cells, and the development and transfer of biological process technology. This serves as the foundation for building our biopharmaceutical process technology development platform.

 

Our company has a team of laboratory personnel with extensive experience in mammalian cell culture R&D and large-scale production. We offer services such as cell strain culture process optimization and cell culture medium optimization, providing better culture processes and process control protocols. This helps improve viral titer/antibody expression levels and quality, enhances process stability, and facilitates technology transfer and scaling up production.

 

We have established reactor culture process technology platforms of various scales for different cell types, including CHO cells, MDCK cells, Vero cells, human diploid cells, BHK21 cells, PK cells, Marc145 cells, MDBK cells, and ST cells. These platforms support the production of most monoclonal antibodies, human vaccines, and veterinary vaccines, and can be directly applied to the development and production of new vaccine processes.

▊ Services：

Vero cell serum-free adherent culture fixed bed reactor production platform for human inactivated rabies vaccine process technology

Vero cell serum-free adherent culture fixed bed reactor production platform for veterinary inactivated rabies vaccine process technology - CHO cells

BHK21 cell low serum suspension culture production platform for veterinary inactivated rabies vaccine process technology

BHK21 cell low serum suspension culture production platform for swine pseudorabies vaccine process technology

BHK21 cell serum-free/low serum suspension culture production platform for foot-and-mouth disease vaccine process technology

MDCK cell serum-free suspension culture production platform for human seasonal influenza vaccine process technology

MDCK cell serum-free suspension culture production platform for highly pathogenic avian influenza vaccine process technology

Human diploid cell low serum adherent culture production platform for varicella vaccine process technology

CHO cell serum-free suspension culture production platform for monoclonal antibodies/recombinant proteins process technology

HEK293 cell serum-free suspension culture stable transprotein production process technology platform

MDBK cell low serum suspension culture production platform for viral diarrhea (BVDV) vaccine process technology

PK15 cell low serum suspension culture production platform for growing porcine circovirus vaccine process technology

ST cell low serum adherent culture fixed bed reactor production platform for classical swine fever vaccine process technology